BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37991211)

  • 21. Thyroglobulin: current status in differentiated thyroid carcinoma (review).
    Harish K
    Endocr Regul; 2006 Jun; 40(2):53-67. PubMed ID: 17100547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative detection of peripheral thyroglobulin mRNA has limited clinical value in the follow-up of thyroid cancer patients.
    Span PN; Sleegers MJ; van den Broek WJ; Ross HA; Nieuwlaat WA; Hermus AR; Sweep CG
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):94-9. PubMed ID: 12542917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
    Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
    Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
    Biscontini G; Possa M; Sara R; Milella M; Rossetti C
    Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma.
    Jeon MJ; Park JW; Han JM; Yim JH; Song DE; Gong G; Kim TY; Baek JH; Lee JH; Shong YK; Kim WB
    J Clin Endocrinol Metab; 2013 Jan; 98(1):153-60. PubMed ID: 23144473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible reasons for different pattern disappearance of thyroglobulin and thyroid peroxidase autoantibodies in patients with differentiated thyroid carcinoma following total thyroidectomy and iodine-131 ablation.
    Thomas D; Liakos V; Vassiliou E; Hatzimarkou F; Tsatsoulis A; Kaldrimides P
    J Endocrinol Invest; 2007 Mar; 30(3):173-80. PubMed ID: 17505148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
    Spencer C; Fatemi S
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels.
    Pellegriti G; Scollo C; Regalbuto C; Attard M; Marozzi P; Vermiglio F; Violi MA; Cianci M; Vigneri R; Pezzino V; Squatrito S
    Clin Endocrinol (Oxf); 2003 May; 58(5):556-61. PubMed ID: 12699436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approach to follow-up of the patient with differentiated thyroid cancer and positive anti-thyroglobulin antibodies.
    Ringel MD; Nabhan F
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3104-10. PubMed ID: 23922347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.
    Chinnappa P; Taguba L; Arciaga R; Faiman C; Siperstein A; Mehta AE; Reddy SK; Nasr C; Gupta MK
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3705-9. PubMed ID: 15292293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum thyroglobulin (Tg) and thyroglobulin antibodies (TgAb) in thyroid cancer.
    Sundram FX; Sethi VK; Aw SE
    Ann Acad Med Singap; 1986 Oct; 15(4):535-8. PubMed ID: 3566173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lowered cutoff of lymph node fine-needle aspiration thyroglobulin in thyroid cancer patients with serum anti-thyroglobulin antibody.
    Jo K; Kim MH; Lim Y; Jung SL; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
    Eur J Endocrinol; 2015 Oct; 173(4):489-97. PubMed ID: 26208979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients.
    Elisei R; Vivaldi A; Agate L; Molinaro E; Nencetti C; Grasso L; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):33-9. PubMed ID: 14715824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies.
    Ritter A; Mizrachi A; Bachar G; Vainer I; Shimon I; Hirsch D; Diker-Cohen T; Duskin-Bitan H; Robenshtok E
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32219303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thyroglobulin mRNA amplification in peripheral blood of patients with differentiated thyroid carcinoma: what does it really mean?].
    Coelho SM; Vaisman M; de Carvalho DP
    Arq Bras Endocrinol Metabol; 2006 Jun; 50(3):427-35. PubMed ID: 16936982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of low-risk well-differentiated thyroid cancer based only on thyroglobulin measurement after recombinant human thyrotropin.
    Wartofsky L;
    Thyroid; 2002 Jul; 12(7):583-90. PubMed ID: 12193302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thyroglobulin mRNA detection in the follow-up of thyroid carcinomas].
    Peuchant O; Corcuff JB; Georges A; Bordenave L
    Ann Biol Clin (Paris); 2005; 63(5):503-6. PubMed ID: 16230285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
    Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.